Wilfried Eberhardt
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Oncology top 0.5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 109
- Lung Cancer Diagnosis and Treatment 70
- Oncology 100
- Lung Cancer Research Studies 45
- Cancer Immunotherapy and Biomarkers 17
- Colorectal Cancer Treatments and Studies 16
- Cancer Treatment and Pharmacology 15
- Co-authors
- Georgios Stamatis (49 shared papers)Martin Stuschke (57 shared papers)Robert Pirker (10 shared papers)Filippo de Marinis (7 shared papers)Joachim von Pawel (11 shared papers)Christoph Pöttgen (35 shared papers)Kenneth J. O’Byrne (5 shared papers)Maciej Krzakowski (5 shared papers)
- Journals
- Journal of Clinical Oncology (41 papers)Annals of Oncology (25 papers)Journal of Thoracic Oncology (17 papers)Lung Cancer (17 papers)European Journal of Cancer (14 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Wilfried Eberhardt
224 papers receiving 7.5k citations
Wilfried Eberhardt's Hit Papers
Peers
Comparison fields: 5 of 123
- Pulmonary and Respiratory Medicine 4.3k
- Oncology 3.0k
- Cancer Research 664
- Radiology, Nuclear Medicine and Imaging 565
- Hepatology 164
Countries citing papers authored by Wilfried Eberhardt
This map shows the geographic impact of Wilfried Eberhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Eberhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Eberhardt more than expected).
Fields of papers citing papers by Wilfried Eberhardt
This network shows the impact of papers produced by Wilfried Eberhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Eberhardt. The network helps show where Wilfried Eberhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Wilfried Eberhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Hit paper breakdown → | 2009 | 1051 |
| 2 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Hit paper breakdown → | 2011 | 455 |
| 3 | Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2013 | 373 |
| 4 | 2010 | 338 | |
| 5 | Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial Hit paper breakdown → | 2015 | 289 |
| 6 | 2015 | 262 | |
| 7 | 1998 | 242 | |
| 8 | 2009 | 194 | |
| 9 | 2008 | 183 | |
| 10 | 2008 | 175 | |
| 11 | 2006 | 168 | |
| 12 | 1999 | 154 | |
| 13 | 2015 | 147 | |
| 14 | 2011 | 117 | |
| 15 | 2011 | 115 | |
| 16 | 2010 | 101 | |
| 17 | 2013 | 96 | |
| 18 | 2007 | 94 | |
| 19 | 2010 | 89 | |
| 20 | 2011 | 80 |
About Wilfried Eberhardt
Wilfried Eberhardt is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 239 papers that have together received 7.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (109 papers), Lung Cancer Diagnosis and Treatment (70 papers), Lung Cancer Research Studies (45 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (15 papers) and Radiomics and Machine Learning in Medical Imaging (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.3k citations), Oncology (3.0k citations), Cancer Research (664 citations), Radiology, Nuclear Medicine and Imaging (565 citations) and Hepatology (164 citations). Wilfried Eberhardt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Georgios Stamatis, Martin Stuschke, Robert Pirker, Filippo de Marinis, Joachim von Pawel, Christoph Pöttgen, Kenneth J. O’Byrne, Maciej Krzakowski, Rodryg Ramlau and Thomas Gauler. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.